Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.59 and traded as low as $0.4681. Elite Pharmaceuticals shares last traded at $0.50, with a volume of 254,398 shares traded.
Elite Pharmaceuticals Stock Performance
The company’s 50 day simple moving average is $0.55 and its 200 day simple moving average is $0.59. The company has a debt-to-equity ratio of 0.06, a quick ratio of 6.34 and a current ratio of 8.04. The stock has a market cap of $537.25 million, a PE ratio of 50.05 and a beta of 0.29.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- Wall Street Stockpicker Names #1 Stock of 2026
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
